What disease is Daprodustat prescribed for?

Daprodustat (Daprodustat) is an oral small molecule drug that is mainly used to treat anemia caused by chronic kidney disease (CKD), especially for adult patients who have received dialysis for at least four months. Due to the long-term decline of renal function in this group of people, insufficient secretion of erythropoietin will eventually occur, and anemia will not only affect the quality of life, but also increase the risk of cardiovascular complications. Traditional treatments mostly rely on exogenous erythropoietin (ESA) preparations, while daprostat provides a new treatment option through a new pharmacological mechanism.

The core mechanism of action is to inhibit prolyl hydroxylase, thereby stabilizing hypoxia-inducible factor (HIF), promoting the secretion of endogenous erythropoietin, and improving iron metabolism. This means that patients can regulate the hematopoietic process through their own physiological pathways. Compared with traditional injectable drugs, daprostat provides the convenience of oral administration, while avoiding problems such as poor compliance and adverse injection site reactions that occur in some patients during long-term injection treatment.

Overseas application experience shows that daprostat is effective in maintaining hemoglobin levels and can help dialysis patients improve their anemia status, thereby reducing clinical manifestations such as fatigue, palpitations, and decreased exercise tolerance. This feature makes it gradually become an important choice in the treatment of anemia related to chronic kidney disease.

In addition to the dialysis population, daprostat may also be expanded to the non-dialysis chronic kidney disease patient population in the future. A number of ongoing clinical studies are validating its safety and effectiveness in a wider population. If further approved, daprostat will cover a larger patient group and have a profound impact on the overall treatment pattern of anemia in chronic kidney disease.

As a prescription drug, dapostat must be used under the guidance of a doctor, and hemoglobin levels and potential side effects need to be monitored during treatment. Although oral administration is relatively convenient, its mechanism of action involves complex regulation of hematopoiesis and iron metabolism, so professional follow-up is indispensable.

Reference materials:https://en.wikipedia.org/wiki/Daprodustat